JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB318256

重组Clostridioides difficile Toxin B/TcdB蛋白(His-tag)

Recombinant Clostridioides difficile Toxin B/TcdB Protein (His-tag)

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Clostridioides difficile Toxin B/TcdB Protein (His-tag) is a Clostridium difficile Fragment protein, in the 2 to 543 aa range, expressed in Escherichia coli, with >95%, <0.005 EU/µg endotoxin level, suitable for Mass Spec.

查看别名

toxB, tcdB, Toxin B

2 Images
Mass Spectrometry - Recombinant Clostridioides difficile Toxin B/TcdB Protein (His-tag) (AB318256)
  • Mass Spec

Supplier Data

Mass Spectrometry - Recombinant Clostridioides difficile Toxin B/TcdB Protein (His-tag) (AB318256)

Mass determination by ESI-TOF. Predicted MW is 64640.00 Da (+/- 10 Da by ESI-TOF). Observed MW is 64510.51 Da.

SDS-PAGE - Recombinant Clostridioides difficile Toxin B/TcdB Protein (His-tag) (AB318256)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Clostridioides difficile Toxin B/TcdB Protein (His-tag) (AB318256)

SDS-PAGE analysis of ab318256 under reducing conditions for 2ug protein.

关键信息

纯度

>95% HPLC

内毒素水平

<0.005 EU/µg

表达系统

Escherichia coli

标签

His tag C-Terminus

应用

Mass Spec

applications

生物活性

No

质谱

LC-MS/MS

访问

P18177

不含动物源

Yes

不含载体蛋白

Yes

种属

Clostridium difficile

存储溶液

pH: 8 Constituents: 1.4586% Sodium chloride, 0.7505% Tris HCl

storage-buffer

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Mass Spec": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

序列信息

[{"sequence":"SLVNRKQLEKMANVRFRTQEDEYVAILDALEEYHNMSENTVVEKYLKLKDINSLTDIYIDTYKKSGRNKALKKFKEYLVTEVLELKNNNLTPVEKNLHFVWIGGQINDTAINYINQWKDVNSDYNVNVFYDSNAFLINTLKKTVVESAINDTLESFRENLNDPRFDYNKFFRKRMEIIYDKQKNFINYYKAQREENPELIIDDIVKTYLSNEYSKEIDELNTYIEESLNKITQNSGNDVRNFEEFKNGESFNLYEQELVERWNLAAASDILRISALKEIGGMYLDVDMLPGIQPDLFESIEKPSSVTVDFWEMTKLEAIMKYKEYIPEYTSEHFDMLDEEVQSSFESVLASKSDKSEIFSSLGDMEASPLEVKIAFNSKGIINQGLISVKDSYCSNLIVKQIENRYKILNNSLNPAISEDNDFNTTTNTFIDSIMAEANADNGRFMMELGKYLRVGFFPDVKTTINLSGPEAYAAAYQDLLMFKEGSMNIHLIEADLRNFEISKTNISQSTEQEMASLWSFDDARAKAQFEEYKRNYFEGSL","proteinLength":"Fragment","predictedMolecularWeight":"64.64 kDa","actualMolecularWeight":"64.51 kDa","aminoAcidEnd":543,"aminoAcidStart":2,"nature":"Recombinant","expressionSystem":null,"accessionNumber":"P18177","tags":[{"tag":"His","terminus":"C-Terminus"}]}]

性能和储存信息

运输条件
Dry Ice
推荐的短期储存条件
-80°C
推荐的长期储存条件
-80°C
False

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

Clostridium difficile Toxin B also known as CD Toxin B or B protein is a potent toxin produced by the bacterium Clostridium difficile. It is one of the major virulence factors alongside Toxin A. This protein carries significant weight approximately 270 kDa. It is expressed in the intestinal tract when Clostridium difficile colonizes and proliferates often leading to severe gastrointestinal conditions. The presence of toxins including both Toxin A and Toxin B contributes to the pathogenicity of C. diff infection.
Biological function summary

This toxin exerts its effects by modifying intracellular signaling pathways disrupting tight junctions and leading to cell apoptosis. Toxin B specifically targets the Rho family of GTPases through glucosylation leading to actin cytoskeleton disorganization and subsequent cell rounding and tissue damage. It functions independently but works in conjunction with Toxin A to enhance virulence. As part of its biological role Toxin B proves essential in the pathogenesis of diseases associated with C. diff infection.

Pathways

Research shows Toxin B's involvement in the disruption of the actin cytoskeleton pathway. This pathway alteration results from direct modification of small GTP-binding proteins such as RhoA Rac and Cdc42. Toxin B's activity leads to loss of cell structure and increased cell lysis showcasing how it fits into major cellular integrity pathways. Its interaction with these proteins places it alongside other microbial toxins that manipulate host cell signaling.

Toxin B has a strong association with Clostridium difficile infection (CDI) which often manifests as pseudomembranous colitis. CDI presents with symptoms such as severe diarrhea and colonic inflammation. Furthermore Toxin B contributes significantly to the disease severity in comparison to other microbial toxins. While Toxin A also plays a role studies suggest that Toxin B's impact on the intestinal epithelium is more severe marking it as a critical target for therapeutic intervention against CDI.

特殊说明

形式

Liquid

常规信息

功能

Toxin B. Precursor of a cytotoxin that targets and disrupts the colonic epithelium, inducing the host inflammatory and innate immune responses and resulting in diarrhea and pseudomembranous colitis (PubMed : 20844489, PubMed : 24919149). TcdB constitutes the main toxin that mediates the pathology of C.difficile infection, an opportunistic pathogen that colonizes the colon when the normal gut microbiome is disrupted (PubMed : 19252482, PubMed : 20844489). Compared to TcdA, TcdB is more virulent and more important for inducing the host inflammatory and innate immune responses (PubMed : 19252482, PubMed : 24919149). This form constitutes the precursor of the toxin : it enters into host cells and mediates autoprocessing to release the active toxin (Glucosyltransferase TcdB) into the host cytosol (PubMed : 10768933, PubMed : 11152463, PubMed : 12941936, PubMed : 17334356, PubMed : 20498856). Targets colonic epithelia by binding to the frizzled receptors FZD1, FZD2 and FZD7, and enters host cells via clathrin-mediated endocytosis (PubMed : 27680706). Frizzled receptors constitute the major host receptors in the colonic epithelium, but other receptors, such as CSPG4 or NECTIN3/PVRL3, have been identified (PubMed : 25547119, PubMed : 26038560, PubMed : 27680706). Binding to carbohydrates and sulfated glycosaminoglycans on host cell surface also contribute to entry into cells (By similarity). Once entered into host cells, acidification in the endosome promotes the membrane insertion of the translocation region and formation of a pore, leading to translocation of the GT44 and peptidase C80 domains across the endosomal membrane (PubMed : 11152463, PubMed : 12941936, PubMed : 24567384). This activates the peptidase C80 domain and autocatalytic processing, releasing the N-terminal part (Glucosyltransferase TcdB), which constitutes the active part of the toxin, in the cytosol (PubMed : 17334356, PubMed : 27571750).. Glucosyltransferase TcdB. Active form of the toxin, which is released into the host cytosol following autoprocessing and inactivates small GTPases (PubMed : 16157585, PubMed : 17901056, PubMed : 24905543, PubMed : 24919149, PubMed : 7777059, PubMed : 8144660). Acts by mediating monoglucosylation of small GTPases of the Rho family (Rac1, RhoA, RhoB, RhoC, RhoG and Cdc42) in host cells at the conserved threonine residue located in the switch I region ('Thr-37/35'), using UDP-alpha-D-glucose as the sugar donor (PubMed : 16157585, PubMed : 17901056, PubMed : 24905543, PubMed : 24919149, PubMed : 7777059). Monoglucosylation of host small GTPases completely prevents the recognition of the downstream effector, blocking the GTPases in their inactive form, leading to actin cytoskeleton disruption and cell death, resulting in the loss of colonic epithelial barrier function (PubMed : 24919149, PubMed : 7777059).

序列相似性

Belongs to the clostridial glucosylating toxin (LCGT) family.

翻译后修饰

Toxin B. Undergoes autocatalytic cleavage to release the N-terminal part (Glucosyltransferase TcdB), which constitutes the active part of the toxin, in the host cytosol (PubMed:12941936, PubMed:17334356, PubMed:27571750). 1D-myo-inositol hexakisphosphate-binding (InsP6) activates the peptidase C80 domain and promotes autoprocessing (PubMed:17334356).

亚细胞定位

Host endosome membrane

产品实验方案

靶点信息

Toxin B. Precursor of a cytotoxin that targets and disrupts the colonic epithelium, inducing the host inflammatory and innate immune responses and resulting in diarrhea and pseudomembranous colitis (PubMed : 20844489, PubMed : 24919149). TcdB constitutes the main toxin that mediates the pathology of C.difficile infection, an opportunistic pathogen that colonizes the colon when the normal gut microbiome is disrupted (PubMed : 19252482, PubMed : 20844489). Compared to TcdA, TcdB is more virulent and more important for inducing the host inflammatory and innate immune responses (PubMed : 19252482, PubMed : 24919149). This form constitutes the precursor of the toxin : it enters into host cells and mediates autoprocessing to release the active toxin (Glucosyltransferase TcdB) into the host cytosol (PubMed : 10768933, PubMed : 11152463, PubMed : 12941936, PubMed : 17334356, PubMed : 20498856). Targets colonic epithelia by binding to the frizzled receptors FZD1, FZD2 and FZD7, and enters host cells via clathrin-mediated endocytosis (PubMed : 27680706). Frizzled receptors constitute the major host receptors in the colonic epithelium, but other receptors, such as CSPG4 or NECTIN3/PVRL3, have been identified (PubMed : 25547119, PubMed : 26038560, PubMed : 27680706). Binding to carbohydrates and sulfated glycosaminoglycans on host cell surface also contribute to entry into cells (By similarity). Once entered into host cells, acidification in the endosome promotes the membrane insertion of the translocation region and formation of a pore, leading to translocation of the GT44 and peptidase C80 domains across the endosomal membrane (PubMed : 11152463, PubMed : 12941936, PubMed : 24567384). This activates the peptidase C80 domain and autocatalytic processing, releasing the N-terminal part (Glucosyltransferase TcdB), which constitutes the active part of the toxin, in the cytosol (PubMed : 17334356, PubMed : 27571750).. Glucosyltransferase TcdB. Active form of the toxin, which is released into the host cytosol following autoprocessing and inactivates small GTPases (PubMed : 16157585, PubMed : 17901056, PubMed : 24905543, PubMed : 24919149, PubMed : 7777059, PubMed : 8144660). Acts by mediating monoglucosylation of small GTPases of the Rho family (Rac1, RhoA, RhoB, RhoC, RhoG and Cdc42) in host cells at the conserved threonine residue located in the switch I region ('Thr-37/35'), using UDP-alpha-D-glucose as the sugar donor (PubMed : 16157585, PubMed : 17901056, PubMed : 24905543, PubMed : 24919149, PubMed : 7777059). Monoglucosylation of host small GTPases completely prevents the recognition of the downstream effector, blocking the GTPases in their inactive form, leading to actin cytoskeleton disruption and cell death, resulting in the loss of colonic epithelial barrier function (PubMed : 24919149, PubMed : 7777059).
See full target information tcdB

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com